Overview

99mTc-ABH2 SPECT/CT in Breast Cancer

Status:
Recruiting

Trial end date:
2024-01-30

Target enrollment:

Participant gender:

Summary

This prospective study will investigate the potential usefulness of 99mTc-ABH2 SPECT/CT in the diagnostic performance and evaluation efficacy of breast cancer.

Phase:

N/A

Details

Lead Sponsor:

Peking Union Medical College Hospital